Grant: Collaborative Research and Development Grants
University of Guelph
$90,000.00
Toward commercialization of a novel fermentation product for enhancing intestine development and productivity of early-weaned pigs
FY 2016-17
Summary
Digestive upsets and growth reductions of newly-weaned pigs are key concerns in pig management. Establishing an intestinal development-enhancing diet will help to optimize pig performance at this critical stage. To this end, we have generated epidermal growth factor (EGF) - expressing L. lactis, and Pichia pastoris via a bioengineering approach. Previous trials in our laboratory have shown that EGF-producing L. lactis enhanced intestinal development and overall animal growth in both mice and pigs. Moreover, oral dosing of the fermentation product (after removal of the genetically modified microorganisms ) also increased intestinal development and growth of early-weaned pigs. To further this technology to commercial application, we plan to better characterize the GMO-free fermentation product, examine stability during feed processing, establish a dose-response relationship in newly-weaned piglets, and to validate the effectiveness of the fermentation product in an environment that represents commercial practices. In addition, we will perform evaluations in vitro and in vivo to determine the safety of application of the fermentation product. It is anticipated that the end product will offer a novel line of feed additives for commercial pork production, while reducing post-weaning growth lag and reliance on use of antibiotics and animal proteins in practical pig diets.
Program
Collaborative Research and Development Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
470408-2014
Name nom
Li, Julang
Department département
Animal Biosciences
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2014
Award amount
90000
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
101
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal production and animal primary products
Area of application fr
Production animale et produits animaux primaires
Research subject code
5511
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal nutrition and husbandry
Research subject fr
Nutrition et élevage des animaux
Partie
2
Nb partie
3
Application title
Toward commercialization of a novel fermentation product for enhancing intestine development and productivity of early-weaned pigs
Keyword
NSERC
Application summary
Digestive upsets and growth reductions of newly-weaned pigs are key concerns in pig management. Establishing an intestinal development-enhancing diet will help to optimize pig performance at this critical stage. To this end, we have generated epidermal growth factor (EGF) - expressing L. lactis, and Pichia pastoris via a bioengineering approach. Previous trials in our laboratory have shown that EGF-producing L. lactis enhanced intestinal development and overall animal growth in both mice and pigs. Moreover, oral dosing of the fermentation product (after removal of the genetically modified microorganisms ) also increased intestinal development and growth of early-weaned pigs. To further this technology to commercial application, we plan to better characterize the GMO-free fermentation product, examine stability during feed processing, establish a dose-response relationship in newly-weaned piglets, and to validate the effectiveness of the fermentation product in an environment that represents commercial practices. In addition, we will perform evaluations in vitro and in vivo to determine the safety of application of the fermentation product. It is anticipated that the end product will offer a novel line of feed additives for commercial pork production, while reducing post-weaning growth lag and reliance on use of antibiotics and animal proteins in practical pig diets.